About the Study: The authors of this Special Communication write that treatment of perinatal Major Depressive Disorder (MDD) should be prioritized during pregnancy. Authors argue that expanding access to maternity, child health, and psychiatric care is a public health imperative, and that structured, evidence-based decision-making can help clinicians and patients balance the risks of untreated depression, treatment benefits, and potential risks associated with SSRI exposure. Authors' institutions include Children's National Hospital, George Washington University School of Medicine, University of British Columbia, BC Children's Hospital Research Institute, Weill Cornell Medical College, Brigham and Women's Hospital, and Harvard Medical School.
Visit JAMA+ Women's Health for editor-curated JAMA Network research, commentary, and multimedia on this and related topics.
